Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -0.50%.

  • Tonix Pharmaceuticals Holding's Return on Capital Employed rose 160.00% to -0.50% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.50%, marking a year-over-year increase of 160.00%. This contributed to the annual value of -0.97% for FY2024, which is N/A change from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Return on Capital Employed stood at -0.50% for Q3 2025, which was down 4.30% from -0.48% recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Return on Capital Employed ranged from a high of -0.48% in Q2 2025 and a low of -2.10% during Q3 2024.
  • In the last 2 years, Tonix Pharmaceuticals Holding's Return on Capital Employed had a median value of -1.01% in 2025 and averaged -1.17%.
  • Data for Tonix Pharmaceuticals Holding's Return on Capital Employed shows a peak YoY soared of 160bps (in 2025) over the last 5 years.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's Return on Capital Employed (Quarterly) stood at -1.24% in 2024, then skyrocketed by 160bps to -0.50% in 2025.
  • Its last three reported values are -0.50% in Q3 2025, -0.48% for Q2 2025, and -0.79% during Q1 2025.